↓ Skip to main content

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a…

Overview of attention for article published in BMC Pulmonary Medicine, July 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
13 Mendeley